This activity is expired and is no longer available for CME credit.


Inhibition of Ang-2: Potential Effect in AMD Treatment Paradigms

Author(s)/Faculty: Carl D. Regillo, MD, FACS; Jeffrey S. Heier, MD
Release Date: 6/30/2020Expiration Date: 6/29/2021
Credit Type: CME / ABO MOCNumber of Credits: 0
Content Type: PodcastProvider:
The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Jeffrey Heier discuss inhibition of angiopoietin-2 and its potential effect on current treatment paradigms for the management of neovascular age-related macular degeneration.